Some Topics Covered: Neuroendocrine cancer, Neuroendocrine tumors (NETs), Patients, Caregivers, Endocrinology, Hormones, Quality of Life, Thyroid Disorders, Immunotherapy, Hormone Replacement Therapy, Testosterone Replacement, GLP-1 Medications, Symptom Management, Survivorship.

ABOUT

Neuroendocrine cancers can sometimes produce hormones that cause symptoms affecting daily life, including flushing, diarrhea, abdominal discomfort, changes in blood sugar, fatigue, and other quality-of-life concerns.

Hormones can have a profound impact on how you feel and function, and in neuroendocrine cancer they can affect far more than tumor growth alone.

Join us for this educational session with Jaydira Del Rivero, a medical oncologist and endocrinologist at the National Cancer Institute, as we explore the "endocrine" side of neuroendocrine cancer and its impact on daily life. Building on her January 2026 overview of functional neuroendocrine tumors (NETs), Dr. Del Rivero will discuss common hormone-related issues that patients may encounter throughout their cancer journey.

Topics will include:

• Thyroid disorders and their symptoms

• Hormone-related side effects associated with immunotherapy

• Testosterone replacement and other hormone replacement therapies, including when they may be appropriate and when they may not

• What patients should know about GLP-1 medications

• Practical considerations for recognizing and managing hormone-related symptoms

  
  

Whether you are living with a functional or nonfunctional NET, this session will provide practical knowledge to help you better understand your symptoms, optimize quality of life, and have informed conversations with your healthcare team.

ABOUT DR. JAYDIRA DEL RIVERO

Jaydira Del Rivero, MD

Medical Oncologist & Endocrinologist

National Cancer Institute, National Institutes of Health

Dr. Del Rivero earned her medical degree from the University of Veracruz in Veracruz, Mexico and completed her internal medicine residency at Woodhull Medical and Mental Health Center/NYU-Langone Medical Center. 

Dr. Del Rivero completed a fellowship in Endocrinology, Diabetes and Metabolism at The Inter-Institute Endocrinology Training Program (IETP) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The National Institute of Child Health and Human Development (NICHD), and The National Institute of Dental and Craniofacial Research (NIDCR) where she was part of a research team developing clinical trials for pheochromocytoma and paraganglioma. She then joined as Assistant Professor at the Montefiore Einstein Center for Cancer Care (MECCC) where she specialized in endocrine oncology involving thyroid cancer, parathyroid and adrenal tumors, and clinical research for gastroenteropancreatic neuroendocrine tumors.

She subsequently completed a second fellowship in medical oncology at the National Cancer Institute (NCI) with a research focus on endocrine malignancies.  Dr. Del Rivero is board certified in Internal Medicine, Endocrinology, Diabetes and Metabolism and Medical Oncology.

​

Dr. Del Rivero is a Physician Scientist in the Developmental Therapeutics Branch. She is the Principal Investigator of the Natural History Study for Neuroendocrine Neoplasm and Adrenocortical Cancer to provide the basis of further development of therapeutic interventions, prevention/screening guidelines, endpoints for future clinical trials, and patient reported outcome measures. Dr. Del Rivero’s current efforts is the development of novel treatment approaches and targeted therapies for endocrine malignancies such as advanced gastroenteropancreatic neuroendocrine tumors, adrenocortical cancer and pheochromocytoma/paraganglioma.

 THANKS TO OUR SPONSORS

The opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by the Neuroendocrine Cancer Foundation or the sponsors of this program. The Neuroendocrine Cancer Foundation does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments.